Plunkett Research Online: uniQure

UNIQURE (QURE:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophelia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in.....



uniQure
Ticker: QURE
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 31 205667394
Fax: 31 205669272
Address: Paasheuvelweg 25a
Amsterdam, 1105 BP Netherlands

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Matthew KapustaCFO/CEO/Director
Philip Astley-SparkeChairman of the Board/Director
See More
uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophelia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in.....See More See More

Auditor: PricewaterhouseCoopers Accountants N.V.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: